United States - English - NLM (National Library of Medicine)

boiron - calcium hydroxide (unii: pf5dzw74vn) (calcium hydroxide - unii:pf5dzw74vn) - pain in the back and heels* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

United States - English - NLM (National Library of Medicine)

amneal-agila, llc - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - calcium chloride 100 mg in 1 ml

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - calcium chloride injection, usp, 10% is indicated: in the treatment of hypocalcemia in conditions requiring a prompt increase in plasma calcium levels (e.g., neonatal tetany and tetany due to parathyroid deficiency, vitamin d deficiency and alkalosis) and for prevention of hypocalcemia during exchange transfusions. as adjunctive therapy in the management of acute symptoms in lead colic. in the treatment of magnesium intoxication due to overdosage of magnesium sulfate. in severe hyperkalemia, to combat deleterious effects on electrocardiographic (ecg) function, pending correction of the potassium level in the extracellular fluid. in cardiac resuscitation, particularly after open heart surgery, when epinephrine fails to improve weak or ineffective myocardial contractions. calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation.

United States - English - NLM (National Library of Medicine)

cardinal health - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - calcium chloride 100 mg in 1 ml

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc. - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml

United States - English - NLM (National Library of Medicine)

app pharmaceuticals, llc - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c

United States - English - NLM (National Library of Medicine)

eci pharmaceuticals, llc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [ see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. calciu